| Loving Eyecare, Inc | |
|
9021 N 121st East Ave Ste 100a, Owasso, OK 74055-5432 | |
| (918) 272-4900 | |
| (918) 272-0224 |
| Full Name | Loving Eyecare, Inc |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 9021 N 121st East Ave Ste 100a, Owasso, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871939033 | NPI | - | NPPES |
| 200104450A | Medicaid | OK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 1158 (Oklahoma) | Primary |
| Provider Name | Donald B Cobb |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1316052533 PECOS PAC ID: 7416978291 Enrollment ID: I20051209000761 |
News Archive
A U.S. clinical study is just getting under way that, if successful, could lead to a non-surgical "cure" for the most common type of cardiac arrhythmia. The study is evaluating a new type of cryogenic catheter co-developed by the National Institute of Standards and Technology.
Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the second quarter of 2010 were approximately DKK 73 million (approximately USD 12 million). Arzerra second quarter net sales in the U.S. and the rest of the world were approximately DKK 64 million (approximately USD 10.5 million) and approximately DKK 9 million (approximately USD 1.5 million) respectively.
There is renewed hope for treatment of a rare genetic condition that causes rapidly accelerated aging and leads to an average life expectancy of 13 years.
The American College of Rheumatology today announced the receipt of two, two-year grants from the Office of Minority Health to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus.
› Verified 3 days ago
| Provider Name | Paul D Loving |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1730246406 PECOS PAC ID: 1052547221 Enrollment ID: I20131118000163 |
News Archive
A U.S. clinical study is just getting under way that, if successful, could lead to a non-surgical "cure" for the most common type of cardiac arrhythmia. The study is evaluating a new type of cryogenic catheter co-developed by the National Institute of Standards and Technology.
Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the second quarter of 2010 were approximately DKK 73 million (approximately USD 12 million). Arzerra second quarter net sales in the U.S. and the rest of the world were approximately DKK 64 million (approximately USD 10.5 million) and approximately DKK 9 million (approximately USD 1.5 million) respectively.
There is renewed hope for treatment of a rare genetic condition that causes rapidly accelerated aging and leads to an average life expectancy of 13 years.
The American College of Rheumatology today announced the receipt of two, two-year grants from the Office of Minority Health to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Loving Eyecare, Inc 9021 N 121st East Ave, 300b, Owasso, OK 74055-5373 Ph: (918) 272-4900 | Loving Eyecare, Inc 9021 N 121st East Ave Ste 100a, Owasso, OK 74055-5432 Ph: (918) 272-4900 |
News Archive
A U.S. clinical study is just getting under way that, if successful, could lead to a non-surgical "cure" for the most common type of cardiac arrhythmia. The study is evaluating a new type of cryogenic catheter co-developed by the National Institute of Standards and Technology.
Genmab A/S announced today that the net sales for Arzerra® (ofatumumab) during the second quarter of 2010 were approximately DKK 73 million (approximately USD 12 million). Arzerra second quarter net sales in the U.S. and the rest of the world were approximately DKK 64 million (approximately USD 10.5 million) and approximately DKK 9 million (approximately USD 1.5 million) respectively.
There is renewed hope for treatment of a rare genetic condition that causes rapidly accelerated aging and leads to an average life expectancy of 13 years.
The American College of Rheumatology today announced the receipt of two, two-year grants from the Office of Minority Health to support the development of programs that aim to increase the recruitment and enrollment in lupus clinical trials of minority populations affected by lupus.
› Verified 3 days ago
Chad J Edwards, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12455 E 100th St N # 110, Owasso, OK 74055 Phone: 918-274-7100 Fax: 918-584-4479 | |
Mr. Robert Rendell Vincent, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12406 E 86th St N, Owasso, OK 74055 Phone: 918-376-2700 Fax: 918-376-2722 | |
Drs. Hinkle & Cash Opt,, Inc. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 12720 E 86th St N, Owasso, OK 74055 Phone: 918-272-5311 | |
Jan Jay Rigney O.d. Inc. Optometrist Medicare: Medicare Enrolled Practice Location: 11880 E 86th St N, Owasso, OK 74055 Phone: 918-272-3937 Fax: 918-272-4251 | |
Dr. Jennifer Lynn Reynolds, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12711 E 86th Pl N Ste 102, Owasso, OK 74055 Phone: 918-376-4100 Fax: 888-299-4619 | |
Vision Source Owasso Optometrist Medicare: Medicare Enrolled Practice Location: 8430 N 123rd East Ave, Owasso, OK 74055 Phone: 918-272-5755 Fax: 918-272-0330 | |
Lanita R Thomas, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 12406 E 86th St N, Owasso, OK 74055 Phone: 918-376-2700 Fax: 918-376-2722 |